BridgeBio Oncology Therapeutics, Inc.

Alphabet Inc. BBOT
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/7/2026
Shares
2,823,126
Value ($000)
25,267
Weight
0.6%
2025 Q3 - 2026 Q1 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).